Ticker Details
Design Therapeutics, Inc.
IPO Date:	March 29, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$575.9M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 3.57%
Avg Daily Range (30 D):	$0.25 | 2.57%
Avg Daily Range (90 D):	$0.28 | 3.36%

Institutional Daily Volume
Avg Daily Volume:	.24M
Avg Daily Volume (30 D):	.22M
Avg Daily Volume (90 D):	.31M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	76
Avg Trade Size (Sh.) (90 D):	99

Institutional Trades
Total Institutional Trades:	296
Avg Institutional Trade:	$1.76M
Avg Institutional Trade (30 D):	$2.31M
Avg Institutional Trade (90 D):	$2.81M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.36M
Avg Closing Trade (30 D):	$.65M
Avg Closing Trade (90 D):	$1.5M
Avg Closing Volume:	189.4K

News

Nov 26, 2025 @ 1:00 PM Design Therapeutics to Participate in Upcoming Inv... Source: Renee Leck

May 7, 2024 @ 10:30 AM Design Therapeutics to Participate in the 2024 RBC... Source: Design Therapeutics, Inc.

Mar 26, 2024 @ 11:37 AM Design Therapeutics And 2 Other Stocks Under $5 In... Source: Avi Kapoor

Mar 19, 2024 @ 8:01 PM Design Therapeutics Outlines Progress Across GeneT... Source: Design Therapeutics, Inc.

Mar 12, 2024 @ 10:30 AM Design Therapeutics to Webcast Fourth Quarter and ... Source: Design Therapeutics, Inc.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.19	$-.3	$-.34
Diluted EPS	$-1.19	$-.3	$-.34
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-67.45M	$-17M	$-19.08M
Operating Income / Loss	$-77.99M	$-19.31M	$-21.57M
Cost of Revenue
Net Cash Flow	$-15.24M	$-4.62M	$6.04M
PE Ratio